JP2010215521A - サガラメを利用した化粧品類及び該化粧品類を用いた海藻療法又は海洋療法 - Google Patents
サガラメを利用した化粧品類及び該化粧品類を用いた海藻療法又は海洋療法 Download PDFInfo
- Publication number
- JP2010215521A JP2010215521A JP2009060680A JP2009060680A JP2010215521A JP 2010215521 A JP2010215521 A JP 2010215521A JP 2009060680 A JP2009060680 A JP 2009060680A JP 2009060680 A JP2009060680 A JP 2009060680A JP 2010215521 A JP2010215521 A JP 2010215521A
- Authority
- JP
- Japan
- Prior art keywords
- water
- cosmetics
- sagarame
- deep
- therapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 54
- 241001474374 Blennius Species 0.000 title claims description 32
- 238000002560 therapeutic procedure Methods 0.000 title claims description 29
- 241000741680 Ecklonia arborea Species 0.000 title description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 103
- 229920000615 alginic acid Polymers 0.000 claims abstract description 20
- 235000010443 alginic acid Nutrition 0.000 claims abstract description 20
- 239000000783 alginic acid Substances 0.000 claims abstract description 17
- 229960001126 alginic acid Drugs 0.000 claims abstract description 17
- 150000004781 alginic acids Chemical class 0.000 claims abstract description 17
- 150000003839 salts Chemical class 0.000 claims abstract description 10
- 150000002500 ions Chemical class 0.000 claims abstract description 7
- 239000012528 membrane Substances 0.000 claims abstract description 4
- 238000001223 reverse osmosis Methods 0.000 claims abstract description 4
- 239000013535 sea water Substances 0.000 claims description 20
- 241000972773 Aulopiformes Species 0.000 claims description 17
- 235000019515 salmon Nutrition 0.000 claims description 17
- 241000269333 Caudata Species 0.000 claims description 12
- 238000012258 culturing Methods 0.000 claims description 4
- 238000000909 electrodialysis Methods 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 3
- 238000005342 ion exchange Methods 0.000 claims description 3
- 101100279436 Caenorhabditis elegans egg-2 gene Proteins 0.000 claims 1
- 230000035800 maturation Effects 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 11
- 239000011707 mineral Substances 0.000 abstract description 11
- 239000004615 ingredient Substances 0.000 abstract description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 20
- 241001228709 Suruga Species 0.000 description 16
- 210000003491 skin Anatomy 0.000 description 16
- 239000000243 solution Substances 0.000 description 11
- 239000001569 carbon dioxide Substances 0.000 description 10
- 229910002092 carbon dioxide Inorganic materials 0.000 description 10
- 235000010755 mineral Nutrition 0.000 description 10
- 230000002265 prevention Effects 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- 230000036541 health Effects 0.000 description 8
- 239000002352 surface water Substances 0.000 description 8
- 238000010792 warming Methods 0.000 description 6
- 241000251730 Chondrichthyes Species 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 235000013601 eggs Nutrition 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- 238000009360 aquaculture Methods 0.000 description 4
- 244000144974 aquaculture Species 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 150000004804 polysaccharides Chemical class 0.000 description 4
- 239000000344 soap Substances 0.000 description 4
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 229940072056 alginate Drugs 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 2
- UBOXGVDOUJQMTN-UHFFFAOYSA-N 1,1,2-trichloroethane Chemical compound ClCC(Cl)Cl UBOXGVDOUJQMTN-UHFFFAOYSA-N 0.000 description 2
- 229920002498 Beta-glucan Polymers 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 229920000855 Fucoidan Polymers 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000199919 Phaeophyceae Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 241001261506 Undaria pinnatifida Species 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000003749 cleanliness Effects 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000003779 hair growth Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 238000009277 landfarming Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- -1 patch Substances 0.000 description 2
- 229920001339 phlorotannin Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000008399 tap water Substances 0.000 description 2
- 235000020679 tap water Nutrition 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- VEEGZPWAAPPXRB-BJMVGYQFSA-N (3e)-3-(1h-imidazol-5-ylmethylidene)-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2\C1=C/C1=CN=CN1 VEEGZPWAAPPXRB-BJMVGYQFSA-N 0.000 description 1
- UOORRWUZONOOLO-OWOJBTEDSA-N (E)-1,3-dichloropropene Chemical compound ClC\C=C\Cl UOORRWUZONOOLO-OWOJBTEDSA-N 0.000 description 1
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 description 1
- LGXVIGDEPROXKC-UHFFFAOYSA-N 1,1-dichloroethene Chemical group ClC(Cl)=C LGXVIGDEPROXKC-UHFFFAOYSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- 229940118148 Aldose reductase inhibitor Drugs 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 229940087064 Beta-glucuronidase inhibitor Drugs 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000007862 Capsicum baccatum Nutrition 0.000 description 1
- 206010010075 Coma hepatic Diseases 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 206010012689 Diabetic retinopathy Diseases 0.000 description 1
- 241000243681 Eisenia bicyclis Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 229920001543 Laminarin Polymers 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010061291 Mineral deficiency Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- CYTYCFOTNPOANT-UHFFFAOYSA-N Perchloroethylene Chemical group ClC(Cl)=C(Cl)Cl CYTYCFOTNPOANT-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- QHTQREMOGMZHJV-UHFFFAOYSA-N Thiobencarb Chemical compound CCN(CC)C(=O)SCC1=CC=C(Cl)C=C1 QHTQREMOGMZHJV-UHFFFAOYSA-N 0.000 description 1
- 229940090496 Urease inhibitor Drugs 0.000 description 1
- 241000607272 Vibrio parahaemolyticus Species 0.000 description 1
- 244000042295 Vigna mungo Species 0.000 description 1
- 235000010716 Vigna mungo Nutrition 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000003288 aldose reductase inhibitor Substances 0.000 description 1
- 229940121369 angiogenesis inhibitor Drugs 0.000 description 1
- 239000004037 angiogenesis inhibitor Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000003788 bath preparation Substances 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 108010033961 beta-glucuronidase inhibitor Proteins 0.000 description 1
- 230000005978 brain dysfunction Effects 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000001728 capsicum frutescens Substances 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 229930002868 chlorophyll a Natural products 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- JOPOVCBBYLSVDA-UHFFFAOYSA-N chromium(6+) Chemical compound [Cr+6] JOPOVCBBYLSVDA-UHFFFAOYSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- KFUSEUYYWQURPO-UPHRSURJSA-N cis-1,2-dichloroethene Chemical group Cl\C=C/Cl KFUSEUYYWQURPO-UPHRSURJSA-N 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000598 endocrine disruptor Substances 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- SJWWTRQNNRNTPU-ABBNZJFMSA-N fucoxanthin Chemical compound C[C@@]1(O)C[C@@H](OC(=O)C)CC(C)(C)C1=C=C\C(C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)C(=O)C[C@]1(C(C[C@H](O)C2)(C)C)[C@]2(C)O1 SJWWTRQNNRNTPU-ABBNZJFMSA-N 0.000 description 1
- AQLRNQCFQNNMJA-UHFFFAOYSA-N fucoxanthin Natural products CC(=O)OC1CC(C)(C)C(=C=CC(=CC=CC(=CC=CC=C(/C)C=CC=C(/C)C(=O)CC23OC2(C)CC(O)CC3(C)C)C)CO)C(C)(O)C1 AQLRNQCFQNNMJA-UHFFFAOYSA-N 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 230000036252 glycation Effects 0.000 description 1
- MNQZXJOMYWMBOU-UHFFFAOYSA-N glyceraldehyde Chemical compound OCC(O)C=O MNQZXJOMYWMBOU-UHFFFAOYSA-N 0.000 description 1
- 201000001059 hepatic coma Diseases 0.000 description 1
- 208000007386 hepatic encephalopathy Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- DBTMGCOVALSLOR-VPNXCSTESA-N laminarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1O[C@@H]1[C@@H](O)C(O[C@H]2[C@@H]([C@@H](CO)OC(O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-VPNXCSTESA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- CEOCDNVZRAIOQZ-UHFFFAOYSA-N pentachlorobenzene Chemical compound ClC1=CC(Cl)=C(Cl)C(Cl)=C1Cl CEOCDNVZRAIOQZ-UHFFFAOYSA-N 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 229930182676 phlorotannins Natural products 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- ODCWYMIRDDJXKW-UHFFFAOYSA-N simazine Chemical compound CCNC1=NC(Cl)=NC(NCC)=N1 ODCWYMIRDDJXKW-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- UOORRWUZONOOLO-UHFFFAOYSA-N telone II Natural products ClCC=CCl UOORRWUZONOOLO-UHFFFAOYSA-N 0.000 description 1
- 229950011008 tetrachloroethylene Drugs 0.000 description 1
- KUAZQDVKQLNFPE-UHFFFAOYSA-N thiram Chemical compound CN(C)C(=S)SSC(=S)N(C)C KUAZQDVKQLNFPE-UHFFFAOYSA-N 0.000 description 1
- 229960002447 thiram Drugs 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000002601 urease inhibitor Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000003911 water pollution Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
【解決手段】アルギン酸を乾燥重量の30%以上含有するサガラメ又は該サガラメの抽出物と、2価イオンを含む海洋深層水の原水又は該原水からつくられる逆浸透膜水、濃縮水、減塩水、イオン交換水、電気透析水及び深層水塩よりなる群から選ばれた少なくとも一つと、を含むことを特徴とするサガラメの化粧品類。
【選択図】図1
Description
2価イオンを含む海洋深層水の原水と、該原水からつくられる逆浸透膜水、濃縮水、減塩水、イオン交換水、電気透析水及び深層水塩とよりなる群から選ばれた少なくとも一つと、
を含むことを特徴とするサガラメの化粧品類(請求項1)。
因みに、請求項1の第2パラグラフにおいては、「群」は、2価イオンを含む海洋深層水の原水と、2価イオンを含む海洋深層水の原水からつくられる逆浸透膜水と濃縮水と減塩水とイオン交換水と電気透析水と深層水塩とよりなるものであり、この群から選ばれた少なくとも一つが用いられる。
Eisenia bicyclis )とは異なるものであり、他の褐藻類とも異なるものである。
懸濁物質は、表層水で平均1.1(0.2〜2.0)mg/L、397m駿河湾深層水で平均0.8(0.3〜1.8)mg/L、687m駿河湾深層水で平均0.5(0.3〜0.9)mg/Lであり、駿河湾深層水で懸濁物質が少なかった。
CODは、表層水では0.5mg/L以上になることがあるが、駿河湾深層水中においては0.5mg/L未満と報告下限値であり、清浄性が確認された。
駿河湾深層水中において、環境省が提示した内分泌攪乱化学物質67種はすべて検出下限以下であった。
大腸菌群は、表層水において1個/mL検出されたことがあったが、駿河湾深層水中においては検出されなかった。
腸炎ビブリオは、表層水において1個/mL検出されたことがあったが、駿河湾深層水中においては検出されなかった。
「人の健康の保護に関する項目」、すなわち、カドミウム、全シアン、鉛、六価クロム、ヒ素、総水銀、PCB、ジクロロメタン、四塩化炭素、1,2‐ジクロロエタン、1,1‐ジクロロエチレン、シス1,2‐ジクロロエチレン、1,1,1‐トリクロロエタン、1,1,2‐トリクロロエタン、テトラクロロエチレン、1,3‐ジクロロプロペン、チウラム、シマジン、チオベンカルブ、ベンゼン、セレン、については駿河湾深層水中においてはすべて報告下限値を下回った。
環境ホルモンの1種と考えられるTBT、TPTは、駿河湾深層水中において検出されなかった。
駿河湾深層水は、「人の健康の保護に関する環境基準」、「水道法施行規則水質基準に関する省令の基準」を満たしており、清浄かつ安全性であることが示唆された。
陸上養殖においては、遊走子、配偶体、胞子体等のサガラメの生長過程において、固着させずに浮遊状態で養殖することが好ましい。従来は、海藻を固着させて生産していたために、大量に生産するためには基質を構成する多数の容器が必要であり、容器の固着面積により生産量が制限を受けていた。さらには、商品として取り扱う場合には、基質から剥離するための多大な時間と労力を要していた。浮遊状態で生産することにより、このような課題が解決されるからである。
(a)海洋深層水で養殖されたサガラメは、天然のサガラメに比較して、アルギン酸含有量が多い(表1参照)。
(b)富栄養性の特徴を有する海洋深層水を利用するとサガラメの成長が早く効率的な養殖が可能である。例えば、本発明者が行なった測定によれば、サガラメ幼体の生長速度は、表層水で3.2mm/day、397m駿河湾深層水で3.7mm/day、687m駿河湾深層水で4.1mm/dayであり、駿河湾深層水で約1.2倍生長速度が速かった。
(c)サガラメを海洋深層水で養殖すれば、二酸化炭素の固定量も増加する。
(d)清浄な海洋深層水で養殖されたサガラメは、人にやさしい化粧品類を提供することができる。
硫酸を100ml加えて、硫酸化多糖類を2回抽出した。この残渣に1.0%炭酸ナトリウム水溶液を100ml加えてアルギン酸を2回抽出した。この抽出液を透析用チューブに入れて2日間透析した後、凍結乾燥し、得られた乾燥物の重量をアルギン酸量とした。
Claims (5)
- アルギン酸を乾燥重量の30%以上含有するサガラメ又は該サガラメの抽出物と、
2価イオンを含む海洋深層水の原水と、該原水からつくられる逆浸透膜水、濃縮水、減塩水、イオン交換水、電気透析水及び深層水塩とよりなる群から選ばれた少なくとも一つと、
を含むことを特徴とするサガラメの化粧品類。 - 前記サガラメは、胞子体又はその一部を培養水で成熟させて遊走子を放出させ、該遊走子から得た配偶体を成熟誘導し精子と卵とを得て、該精子と卵とを受精させて得た胞子体を培養してなる、人工管理下で養殖されたものであることを特徴とする請求項1に記載のサガラメの化粧品類。
- 前記サガラメは、海洋深層水で養殖されたものであることを特徴とする請求項2に記載のサガラメの化粧品類。
- 前記サガラメを乾燥させた後に細かくし、これを容器内の水に浸漬して水溶性成分を抽出し、得られた抽出物に対し海洋深層水の電気透析水を該抽出物の30〜50重量%加えて撹拌してなる粘性が増した溶液を含むことを特徴とする請求項1〜3のいずれかに記載のサガラメの化粧品類。
- 請求項1〜4のいずれかに記載のサガラメの化粧品類を用いることを特徴とする海藻療法又は海洋療法。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009060680A JP2010215521A (ja) | 2009-03-13 | 2009-03-13 | サガラメを利用した化粧品類及び該化粧品類を用いた海藻療法又は海洋療法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009060680A JP2010215521A (ja) | 2009-03-13 | 2009-03-13 | サガラメを利用した化粧品類及び該化粧品類を用いた海藻療法又は海洋療法 |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2010215521A true JP2010215521A (ja) | 2010-09-30 |
Family
ID=42974762
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009060680A Pending JP2010215521A (ja) | 2009-03-13 | 2009-03-13 | サガラメを利用した化粧品類及び該化粧品類を用いた海藻療法又は海洋療法 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2010215521A (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013087057A (ja) * | 2011-10-13 | 2013-05-13 | Ichimaru Pharcos Co Ltd | アクアポリン産生増強製剤 |
JP2013155141A (ja) * | 2012-01-31 | 2013-08-15 | Mikimoto Pharmaceut Co Ltd | 化粧料 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002020224A (ja) * | 2000-07-07 | 2002-01-23 | Nonogawa Shoji Kk | 皮膚外用剤 |
JP2003342160A (ja) * | 2002-03-18 | 2003-12-03 | Toyama Prefecture | 皮膚外用剤 |
JP2006262823A (ja) * | 2005-03-25 | 2006-10-05 | Shizuoka Prefecture | 海藻類の種苗生産方法 |
JP2007053975A (ja) * | 2005-08-25 | 2007-03-08 | Aichi Prefecture | 藻場形成方法及び藻場形成用種苗含有粘液 |
JP2007302646A (ja) * | 2006-05-12 | 2007-11-22 | Yua:Kk | アルゴテラピ−又はアルゴエステ用海藻パック剤、その利用方法並びにその利用セット |
JP2008054530A (ja) * | 2006-08-29 | 2008-03-13 | Hokkaido Univ | 多年生コンブの栽培方法 |
-
2009
- 2009-03-13 JP JP2009060680A patent/JP2010215521A/ja active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002020224A (ja) * | 2000-07-07 | 2002-01-23 | Nonogawa Shoji Kk | 皮膚外用剤 |
JP2003342160A (ja) * | 2002-03-18 | 2003-12-03 | Toyama Prefecture | 皮膚外用剤 |
JP2006262823A (ja) * | 2005-03-25 | 2006-10-05 | Shizuoka Prefecture | 海藻類の種苗生産方法 |
JP2007053975A (ja) * | 2005-08-25 | 2007-03-08 | Aichi Prefecture | 藻場形成方法及び藻場形成用種苗含有粘液 |
JP2007302646A (ja) * | 2006-05-12 | 2007-11-22 | Yua:Kk | アルゴテラピ−又はアルゴエステ用海藻パック剤、その利用方法並びにその利用セット |
JP2008054530A (ja) * | 2006-08-29 | 2008-03-13 | Hokkaido Univ | 多年生コンブの栽培方法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013087057A (ja) * | 2011-10-13 | 2013-05-13 | Ichimaru Pharcos Co Ltd | アクアポリン産生増強製剤 |
JP2013155141A (ja) * | 2012-01-31 | 2013-08-15 | Mikimoto Pharmaceut Co Ltd | 化粧料 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Asaikkutti et al. | Dietary supplementation of green synthesized manganese-oxide nanoparticles and its effect on growth performance, muscle composition and digestive enzyme activities of the giant freshwater prawn Macrobrachium rosenbergii | |
Pati et al. | Uses of seaweed and its application to human welfare: A review | |
CH714997B1 (de) | Festes Präparat für die Zubereitung eines funktionellen Getränks und Verfahren zu seiner Herstellung. | |
Murugaiyan et al. | Proximate composition of marine macro algae from Seeniappa Dharka, Gulf of Mannar region, Tamil Nadu | |
KR101611930B1 (ko) | 해양식물 혼합추출물을 함유하는 세라마이드 생합성촉진 및 피부장벽강화 화장료 조성물 | |
CN101690538A (zh) | 一种低氟南极磷虾蛋白质基料的制备方法 | |
CN104432318A (zh) | 一种小球藻饮料的制作方法 | |
KR20090060206A (ko) | 해양심층수 및 해양콜라겐을 함유하는 비누 조성물 | |
CN104026329B (zh) | 一种天然高含量硒源大米肽的提取方法 | |
KR20110114362A (ko) | 클로렐라와 해양심층수를 활용한 기능성 음료 조성물 | |
CN104996770A (zh) | 一种猫用饮料及其制备方法 | |
JP2010215521A (ja) | サガラメを利用した化粧品類及び該化粧品類を用いた海藻療法又は海洋療法 | |
CN104256174A (zh) | 松江鲈鱼用复合免疫增强剂及其制备方法 | |
CN104288286B (zh) | 一种含藏边大黄的药物组合物、提取液及其应用 | |
CN108739562A (zh) | 一种鲍鱼养殖方法 | |
CN107555611A (zh) | 一种高效渔用水质改良剂及其制备方法和应用 | |
US20080193597A1 (en) | Food supplement comprising spirulina and a plant-based product of the aloe genus, and the cosmetic use thereof | |
KR20180097494A (ko) | 제주도 용암해수로부터 분리된 부착성 규조류를 이용한 화장품용 조성물 및 이를 이용한 화장품 제조방법 | |
Umoh et al. | Mineral iron content of Commelina benghalensis, Paspalum vaginatum, Ipomoea pes-caprae and Philoxerus vermiculeris found along Ibeno Coastline, Nigeria | |
Magdugo | Marine seaweeds with economic importance in the philippines: Valuation of six specie Caulerpa racemosa (Forsskål), Ulva fasciata (Delile), Sargassum polycystum (C. Agardh), Sargassum ilicifolium (Turner) C. Agardh, Halymenia durvillei (Bory de Saint-Vincent), and Halymenia dilatata (Zanardini) from the Philippines | |
JP2004154675A (ja) | 構造化濃縮深層水を用いた環境浄化剤 | |
KR20060070523A (ko) | 나노 캡슐화 된 스피루리나 추출물이 함유된 남성용 기능성스킨, 로션 및 클렌징크림의 제조방법 | |
CN104012871A (zh) | 一种虾蛄保健面条及其制备方法 | |
CN103535298A (zh) | 一种利用纳米缓释饲料养殖桂花鱼的方法 | |
Yangthong | Chemical and mineral compositions of Sargassum spp. from Bo Mao beach, Chumphon province, Thailand |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120119 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20120119 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20130418 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130423 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130619 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140312 |